Skip to main content

Granules USA, Inc.

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20211
Download CSV

FDA Recall Terminated Historical recordClass II

Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, Sy.No. 160/A, 161/E, 162, &174/A, Gagillapur Village, Dundigal-Gandimalsamma Monday, Medchai-Maikhajgir District - 500043, Telangana, INDIA. NDC 62207-762-36

by Granules USA, Inc.

Reason
CGMP Deviations
Published
September 8, 2021
Distribution
NY

View recall →

Showing 1–1 of 1 results

This page lists recalls that name Granules USA, Inc. as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.